Roche Products Limited has been reinstated to membership of the Association of the British Pharmaceutical Industry (ABPI) following the company’s suspension from 14 July 2008.
The ABPI Board of Management decided that Roche should be reinstated to membership with effect from February 16, but that the ABPI Board would review the report of a further audit to be held in November 2009 to ensure that progress was being maintained.
Roche was suspended from membership for a minimum of six months after it was found to be in breach of the Code, including Clause 2 which deals with activities that bring discredit on, or reduce confidence in, the pharmaceutical industry. ABPI Press Release, Monday 14 July 2008.
For further information, please contact: ABPI Press office 020 7747 1410